Finnmed Biotech Private Limited
About Finnmed Biotech Private Limited
Data last updated:
Finnmed Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC171292. Its GSTIN is 27AADCF1427C1Z5 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ramesh Shrirang Kedar and Pratap Popat Somwanshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor Office No. 5&6 Kute Complex Nr. Hanuman Mandir Akurdi Main Road, Pune, Maharashtra, India – 411035.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.32 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹5.54 Lakh (net margin 2.4%) and EBITDA of ₹8.97 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 2% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Finnmed Biotech Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFirst Floor Office No. 5&6 Kute Complex Nr. Hanuman Mandir Akurdi Main Road, Pune, Maharashtra, India – 411035
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Finnmed Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Finnmed Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Finnmed Biotech Private Limited, buy the company report.
Financials of Finnmed Biotech Private Limited
FY 2025 filings availableFinnmed Biotech Private Limited reported revenue of ₹2.32 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 5% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Finnmed Biotech Private Limited, buy the company report.
Board of directors of Finnmed Biotech Private Limited
Finnmed Biotech has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Shrirang Kedar | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
| Pratap Popat Somwanshi Also directs: Glowmax Solution LLP | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
| Jayshree Gorakshnath Kale | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
| Rajesh Sagaji Patil Also directs: Sharpecoblox LLP, Ekveera Edutech LLP | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
| Vilas Ganpat Kute | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
Peer comparison
Finnmed Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brewster Pharma Private Limited | ₹2.32 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| Igp Medi Ventures Private Limited | ₹2.32 Cr (FY 2025) | -32.0% | Lucknow, Uttar Pradesh, India | |||
| Clifford Pharmaceuticals Private Limited | ₹2.32 Cr (FY 2024) | 19.0% | New Delhi, Delhi, India | |||
| Finnmed Biotech Private Limitedthis company | ₹2.32 Cr (FY 2024) | ₹5.54 Lakh | 2.4% | 5.0% | 6 | Pune, Maharashtra, India |
| Zorex Pharma Private Limited | ₹2.32 Cr (FY 2024) | -85.0% | Ahmedabad, Gujarat, India | |||
| Pitrashish Marketing Enterprises Private Limited | ₹2.32 Cr (FY 2025) | -28.0% | Kolkata, West Bengal, India | |||
| Sciana Instruments Private Limited | ₹2.31 Cr (FY 2024) | 57.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Finnmed Biotech Private Limited, buy the company report.
Auditor
Finnmed Biotech Private Limited is audited by S U N S V G & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S U N S V G & ASSOCIATES | FY 2018 | 118693W |
Shareholding
The shareholding of Finnmed Biotech Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Finnmed Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Finnmed Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Finnmed Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Finnmed Biotech Private Limited has a workforce of 6 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Finnmed Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCF1427C1Z5 | Maharashtra | Active | 02 Aug 2017 |
To see the full GST registrations and return filing status of Finnmed Biotech Private Limited, buy the company report.
Recent activity
Finnmed Biotech Private Limited has 6 board changes on record since 2017: 5 appointments and 1 cessation. The latest: Deepak Sayajirao Lokhande ceased to be Director on 25 Nov 2021.
Frequently asked questions
Finnmed Biotech is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 July 2017 (9+ years old) and is registered under CIN U74999PN2017PTC171292.
Finnmed Biotech has 5 current directors:
- Ramesh Shrirang Kedar - Director
- Pratap Popat Somwanshi - Director
- Jayshree Gorakshnath Kale - Director
- Rajesh Sagaji Patil - Director
- Vilas Ganpat Kute - Director
The latest financial statements of Finnmed Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Finnmed Biotech is 27AADCF1427C1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Finnmed Biotech is U74999PN2017PTC171292. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Finnmed Biotech was incorporated on 05 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Finnmed Biotech by revenue are Brewster Pharma Private Limited, Igp Medi Ventures Private Limited, Clifford Pharmaceuticals Private Limited, Zorex Pharma Private Limited, Pitrashish Marketing Enterprises Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Deepak Sayajirao Lokhande ceased to be Director on 25 Nov 2021. Jayshree Gorakshnath Kale was appointed as Director on 05 Jul 2017. Pratap Popat Somwanshi was appointed as Director on 05 Jul 2017. Finnmed Biotech has 6 board changes on record in total.
The registered office of Finnmed Biotech is at First Floor Office No. 5&6 Kute Complex Nr. Hanuman Mandir Akurdi Main Road, Pune, Maharashtra, India – 411035.
Finnmed Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Finnmed Biotech is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
